Huntington Bancshares Inc ha un obiettivo di prezzo consensuale di $17.87, basato sulle valutazioni degli ultimi 24 analisti. Il massimo è $21 emesso da Jefferies il settembre 3, 2025, mentre il minimo è $12 emesso da Morgan Stanley il luglio 25, 2023. Le ultime 3 valutazioni degli analisti sono state pubblicate da Truist Securities, Jefferies e DA Davidson il settembre 12, 2025, settembre 3, 2025 e luglio 21, 2025. Con un obiettivo di prezzo medio di $20.33 tra Truist Securities, Jefferies e DA Davidson, c'è un cambiamento implicito del 17.20% upside per Huntington Bancshares Inc secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
09/12/2025 | 15.27% | Truist Securities | $19 → $20 | Maintains | Buy | |||
09/03/2025 | 21.04% | Jefferies | $19 → $21 | Maintains | Buy | |||
07/21/2025 | 15.27% | DA Davidson | $18 → $20 | Maintains | Buy | |||
07/08/2025 | 21.04% | Raymond James | $18 → $21 | Reiterates | Strong Buy → Strong Buy | |||
07/03/2025 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
07/02/2025 | 15.27% | Citigroup | $19 → $20 | Maintains | Buy | |||
06/13/2025 | 9.51% | Truist Securities | $18 → $19 | Maintains | Buy | |||
05/23/2025 | 3.75% | Truist Securities | $17 → $18 | Maintains | Buy | |||
05/21/2025 | 15.27% | Jefferies | → $20 | Initiates | → Buy | |||
04/22/2025 | -2.02% | Truist Securities | $21 → $17 | Maintains | Buy | |||
04/21/2025 | 3.75% | RBC Capital | $20 → $18 | Maintains | Outperform | |||
04/21/2025 | -2.02% | Keefe, Bruyette & Woods | $18 → $17 | Maintains | Market Perform | |||
04/21/2025 | -4.9% | Stephens & Co. | $16.5 → $16.5 | Reiterates | Equal-Weight → Equal-Weight | |||
04/21/2025 | 3.75% | Raymond James | $20 → $18 | Reiterates | Strong Buy → Strong Buy | |||
04/03/2025 | -7.78% | JP Morgan | $18.5 → $16 | Maintains | Overweight | |||
03/24/2025 | 3.75% | Citigroup | $20 → $18 | Maintains | Buy | |||
03/13/2025 | 15.27% | Morgan Stanley | $22 → $20 | Maintains | Overweight | |||
03/07/2025 | 3.75% | Baird | $18 → $18 | Upgrade | Neutral → Outperform | |||
02/07/2025 | 6.63% | Stephens & Co. | $18.5 → $18.5 | Reiterates | Equal-Weight → Equal-Weight | |||
01/21/2025 | -2.02% | Piper Sandler | $17.5 → $17 | Maintains | Underweight | |||
01/21/2025 | 6.63% | Stephens & Co. | $18.5 → $18.5 | Reiterates | Equal-Weight → Equal-Weight | |||
01/21/2025 | 15.27% | RBC Capital | $20 → $20 | Reiterates | Outperform → Outperform | |||
01/21/2025 | 21.04% | Truist Securities | $19 → $21 | Maintains | Buy | |||
01/07/2025 | 9.51% | Truist Securities | → $19 | Initiates | → Buy | |||
01/06/2025 | 9.51% | Barclays | $17 → $19 | Maintains | Equal-Weight | |||
12/23/2024 | 15.27% | RBC Capital | $20 → $20 | Reiterates | Outperform → Outperform | |||
12/12/2024 | 15.27% | RBC Capital | $20 → $20 | Reiterates | Outperform → Outperform | |||
12/04/2024 | 9.51% | Keefe, Bruyette & Woods | $16 → $19 | Maintains | Market Perform | |||
12/04/2024 | 15.27% | JP Morgan | $18.5 → $20 | Assumes | → Overweight | |||
12/03/2024 | 0.86% | Piper Sandler | $15 → $17.5 | Maintains | Underweight | |||
11/26/2024 | 15.27% | Goldman Sachs | $16.25 → $20 | Maintains | Buy | |||
11/19/2024 | 21.04% | Citigroup | $18 → $21 | Maintains | Buy | |||
10/30/2024 | 3.75% | Evercore ISI Group | $17 → $18 | Maintains | Outperform | |||
10/21/2024 | 0.86% | DA Davidson | $16.5 → $17.5 | Maintains | Buy | |||
10/18/2024 | -2.02% | Barclays | $15 → $17 | Maintains | Equal-Weight | |||
10/18/2024 | -13.54% | Piper Sandler | $14 → $15 | Maintains | Underweight | |||
10/18/2024 | -2.02% | RBC Capital | $17 → $17 | Reiterates | Outperform → Outperform | |||
10/02/2024 | -2.02% | Evercore ISI Group | $17.5 → $17 | Maintains | Outperform | |||
08/05/2024 | 3.75% | Morgan Stanley | $16 → $18 | Maintains | Overweight | |||
07/26/2024 | -13.54% | Baird | $15 → $15 | Downgrade | Outperform → Neutral | |||
07/22/2024 | -7.78% | Morgan Stanley | $15 → $16 | Maintains | Overweight | |||
07/22/2024 | 3.75% | Citigroup | $17 → $18 | Maintains | Buy | |||
07/22/2024 | -2.02% | B of A Securities | $15 → $17 | Maintains | Buy | |||
07/22/2024 | -7.78% | Argus Research | $15 → $16 | Maintains | Buy | |||
07/22/2024 | -2.02% | RBC Capital | $16 → $17 | Maintains | Outperform | |||
07/22/2024 | -22.19% | Piper Sandler | $11.5 → $13.5 | Maintains | Underweight | |||
07/09/2024 | -16.43% | Keefe, Bruyette & Woods | $15 → $14.5 | Maintains | Market Perform | |||
07/03/2024 | -13.54% | Jefferies | $16 → $15 | Maintains | Buy | |||
06/27/2024 | -4.9% | JP Morgan | $17 → $16.5 | Maintains | Overweight | |||
06/25/2024 | -13.54% | Evercore ISI Group | $16.5 → $15 | Maintains | Outperform | |||
06/14/2024 | -2.02% | JP Morgan | $18 → $17 | Maintains | Overweight | |||
06/14/2024 | -33.72% | Piper Sandler | $13.5 → $11.5 | Downgrade | Neutral → Underweight | |||
06/13/2024 | -13.54% | UBS | $16 → $15 | Maintains | Buy | |||
06/12/2024 | -13.54% | Morgan Stanley | $16 → $15 | Maintains | Overweight | |||
06/11/2024 | -13.54% | Keefe, Bruyette & Woods | $15 → $15 | Maintains | Market Perform | |||
06/11/2024 | -7.78% | RBC Capital | $16 → $16 | Reiterates | Outperform → Outperform | |||
05/28/2024 | 3.75% | JP Morgan | $16 → $18 | Upgrade | Neutral → Overweight | |||
04/22/2024 | -13.54% | Stephens & Co. | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight | |||
04/22/2024 | -7.78% | Morgan Stanley | $16 → $16 | Maintains | Overweight | |||
04/09/2024 | -7.78% | RBC Capital | $15 → $16 | Maintains | Outperform | |||
04/08/2024 | -7.78% | Jefferies | $14 → $16 | Upgrade | Hold → Buy | |||
04/08/2024 | -7.78% | B of A Securities | $14 → $16 | Upgrade | Neutral → Buy | |||
04/05/2024 | -13.54% | Keefe, Bruyette & Woods | $14 → $15 | Maintains | Market Perform | |||
04/04/2024 | -7.78% | JP Morgan | $15 → $16 | Maintains | Neutral | |||
04/01/2024 | -13.54% | Stephens & Co. | → $15 | Reiterates | Equal-Weight → Equal-Weight | |||
03/28/2024 | -7.78% | Evercore ISI Group | $15 → $16 | Maintains | Outperform | |||
03/08/2024 | -19.31% | Piper Sandler | $13 → $14 | Maintains | Neutral | |||
02/27/2024 | -10.66% | DA Davidson | $14 → $15.5 | Upgrade | Neutral → Buy | |||
02/14/2024 | -13.54% | UBS | $14 → $15 | Upgrade | Neutral → Buy | |||
02/07/2024 | -7.78% | Morgan Stanley | $13 → $16 | Maintains | Overweight | |||
01/25/2024 | -13.54% | Citigroup | $14 → $15 | Maintains | Buy | |||
01/22/2024 | -13.54% | JP Morgan | $14.5 → $15 | Maintains | Neutral | |||
01/05/2024 | -16.43% | JP Morgan | $14 → $14.5 | Maintains | Neutral | |||
01/03/2024 | -13.54% | Evercore ISI Group | $10.5 → $15 | Upgrade | In-Line → Outperform | |||
01/02/2024 | -13.54% | Barclays | $12 → $15 | Upgrade | Underweight → Equal-Weight | |||
12/26/2023 | -13.54% | Raymond James | $13 → $15 | Maintains | Strong Buy | |||
12/18/2023 | -13.54% | RBC Capital | $12 → $15 | Maintains | Outperform | |||
12/18/2023 | -19.31% | Goldman Sachs | $12.5 → $14 | Maintains | Buy | |||
12/12/2023 | -19.31% | JP Morgan | $12 → $14 | Maintains | Neutral | |||
12/04/2023 | -25.07% | Morgan Stanley | $12 → $13 | Maintains | Overweight | |||
10/23/2023 | -25.07% | Raymond James | $15 → $13 | Maintains | Strong Buy | |||
10/23/2023 | -30.84% | RBC Capital | $13 → $12 | Maintains | Outperform | |||
10/23/2023 | -30.84% | Barclays | $13 → $12 | Maintains | Underweight | |||
10/23/2023 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
10/05/2023 | -30.84% | JP Morgan | $13 → $12 | Maintains | Neutral | |||
09/29/2023 | -30.84% | Citigroup | → $12 | Initiates | → Buy | |||
09/15/2023 | -30.84% | Piper Sandler | $12.5 → $12 | Maintains | Neutral | |||
07/25/2023 | -30.84% | Morgan Stanley | $12 → $12 | Reiterates | Overweight → Overweight | |||
07/25/2023 | -22.19% | Goldman Sachs | $12 → $13.5 | Maintains | Buy | |||
07/25/2023 | -25.07% | JP Morgan | $12 → $13 | Upgrade | Underweight → Neutral | |||
07/24/2023 | -25.07% | DA Davidson | $12 → $13 | Maintains | Neutral | |||
07/24/2023 | -19.31% | RBC Capital | → $14 | Reiterates | Outperform → Outperform | |||
07/24/2023 | -25.07% | Stephens & Co. | $12 → $13 | Maintains | Equal-Weight | |||
07/24/2023 | -13.54% | Raymond James | $14 → $15 | Maintains | Strong Buy | |||
07/07/2023 | -30.84% | Morgan Stanley | $12 → $12 | Reiterates | Overweight → Overweight | |||
07/06/2023 | -19.31% | Raymond James | $15 → $14 | Maintains | Strong Buy | |||
05/19/2023 | -30.84% | Goldman Sachs | $13.5 → $12 | Maintains | Buy | |||
05/16/2023 | -30.84% | Morgan Stanley | $13 → $12 | Maintains | Overweight | |||
04/21/2023 | -25.07% | Piper Sandler | $12 → $13 | Maintains | Neutral | |||
04/21/2023 | -13.54% | RBC Capital | $16 → $15 | Maintains | Outperform |
L'ultimo obiettivo di prezzo per Huntington Bancshares (NASDAQ:HBAN) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $20.00 prevedendo che HBAN raggiunga rise entro 12 mesi (un possibile 15.27% upside).
L'ultima valutazione degli analisti per Huntington Bancshares (NASDAQ:HBAN) è stato fornita da Truist Securities e Huntington Bancshares mantenuto il suo rating buy.
L'ultima revisione al rialzo di Huntington Bancshares Inc è avvenuta il luglio 3, 2025, quando Wolfe Research ha alzato il suo obiettivo di prezzo a N/A. In precedenza Wolfe Research aveva a peer perform per Huntington Bancshares Inc.
L'ultima revisione al ribasso di Huntington Bancshares Inc si è verificata il luglio 26, 2024, quando Baird ha modificato il suo obiettivo di prezzo da $15 a $15 per Huntington Bancshares Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di Huntington Bancshares e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di Huntington Bancshares è stata depositata il settembre 12, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a settembre 12, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di Huntington Bancshares (HBAN) è stata una mantenuto con un obiettivo di prezzo di $19.00 a $20.00. Il prezzo attuale a cui Huntington Bancshares (HBAN) è scambiato è $17.35, che è out of del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.